Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06895447Phase 2Recruiting
Phase 2, open-label, single-arm trial, sponsored by Jiangsu Provincial People's Hospital. Primary endpoint: Safety and clinical efficacy of robotic radical gastrectomy following neoadjuvant therapy. Started Nov 2024; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06895447.